Table 3.
Isolate | ST1 | ST2 | ST3 | ST3 | ST3 | ST4 | ST4 | ST6 | ST7 | ST8 | ST9 |
---|---|---|---|---|---|---|---|---|---|---|---|
NandII | Flemming | DMP/08-326 | DMP/IH:478 | DMP/08-1043 | DMP/02-328 | DMP/10-212 | SSI:754 | B | DMP/08-128 | F5323 | |
GenBank Accession | EF494740 | KU900235 | HQ909886 | HQ909888 | HQ909887 | EF494739 | KU900236 | KU900237 | CU914152 | KU900238 | KU900239 |
rpl2–rps19 | 8 | 8 | 11 | 11 | 11 | 8 | 8 | 8 | 11 | 11 | 8 |
rps19–rps3 | – | – | – | – | – | 4 | 4 | 4 | – | – | 4 |
rps3–rpl16 | – | – | – | – | – | – | – | – | – | 10 | – |
nad7–orf160a | 56 | 56 | 56 | 55 | 56 | 56 | 56 | 56 | 56 | 56 | 56 |
orf160–nad4 | – | – | – | – | – | – | – | 10 | – | – | 10 |
nad4–rps4b | – | 7 | – | – | – | – | 11 | – | – | – | – |
rps8–rpl6 | – | – | – | – | – | – | – | 8 | – | – | 8 |
rpl6–rps2 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 8 | 11 | 11 | 8 |
rps2–rpl14 | – | – | – | – | – | – | – | – | – | 17 | – |
nad2–rps10 | – | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
rps10–nad9 | 23 | 23 | 8 | 8 | 8 | 20 | 20 | 23 | 26 | 23 | 20 |
nad9–rps11 | – | – | – | – | – | – | – | 1 | – | – | 1 |
nad1–nad4L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
rps12–tRNAAsn | 7 | 38 | 7 | 38 | 38 | 7 | 7 | 38 | 69 | 38 | 69 |
Total overlap | 115 | 163 | 113 | 143 | 144 | 126 | 137 | 176 | 193 | 237 | 204 |
aThe triplet and the single letter amino acid letter designation is given.
bThe absence in some STs of an initiation codon in rps4 and the presence of in-frame stop codons in orf160 complicates the calculation of the overlap lengths involving these genes as it is unclear where the true start of translation is. Accordingly, we have annotated the start of rps4 as the first triplet after the stop codon of the preceding nad4 gene and the start of orf160 as the conserved ATG upstream of the in-frame stop codon(s); the overlap lengths involving these two genes must be viewed as tentative.